Foam sclerotherapy vs foam sclerotherapy
It is very uncertain whether foam sclerotherapy changes complications ‐ thromboembolic compared with foam sclerotherapy (very low certainty).
- RR 1.47 [0.41, 5.33]3 studies · 371 participantsVery low
It is very uncertain whether foam sclerotherapy changes complications ‐ thromboembolic compared with foam sclerotherapy (very low certainty).
Foam sclerotherapy showed no clear difference in residual varicose veins compared with foam sclerotherapy (moderate certainty).
Assisted hatching showed no clear difference in live births per woman randomised compared with no assisted hatching (low certainty).
Assisted hatching may leads to higher multiple pregnancy rate per woman randomised compared with no assisted hatching (low certainty).
Assisted hatching may leads to higher clinical pregnancy rate per woman randomised compared with no assisted hatching (low certainty).
It is very uncertain whether assisted hatching changes miscarriage rate per woman randomised compared with no assisted hatching (very low certainty).
It is very uncertain whether autologous blood or PRP changes treatment success (> 25% improvement in pain or function) compared with placebo at 3 months' follow‐up (very low certainty).
It is very uncertain whether autologous blood or PRP changes withdrawal due to adverse events  compared with placebo at 3 months' follow‐up (very low certainty).
The intervention showed no clear difference in leg pain ‒short‐term (moderate certainty).
The intervention showed no clear difference in disability ‒short‐term (> 2 weeks but ≤ 3 months) Disability… (moderate certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
It is very uncertain whether CSII changes caesarean section compared with MDI: maternal outcomes (very low certainty).